# Critic Report -- Cycle 1
## Session: session-20260328-123317
## Fields: Statistical mechanics (bond percolation theory) x Tumor immunology (ECM-mediated immune exclusion)
## Date: 2026-03-28
## Critic: Opus | Cycle: 1

---

## Summary

| Hypothesis | Verdict | Revised Confidence | Key Issue |
|---|---|---|---|
| H1: LOX Crosslink Density = Bond Occupation Probability | CONDITIONAL_PASS | 5/10 | Core mapping is sound but lattice abstraction of disordered fiber network is a serious conceptual gap |
| H2: Universal Critical Exponent nu = 0.88 | CONDITIONAL_PASS | 4/10 | Active particles likely break universality; measuring near p_c is extremely difficult |
| H3: Subdiffusive MSD Exponent alpha = 0.53 | CONDITIONAL_PASS | 4/10 | T cell run-and-pause behavior independently produces subdiffusion, confounding the percolation signature |
| H4: BAPN Dose-Response Phase Transition | CONDITIONAL_PASS | 5/10 | Clean testable prediction but citation error (Tang 1983, not 2017) and p(dose) mapping is unknown |
| H5: Finite-Size Scaling Biopsy Bias | KILL | 2/10 | The 0.6% shift is quantitatively negligible; intratumoral heterogeneity dominates by orders of magnitude |
| H6: Dynamic Percolation MMP/LOX Windows | CONDITIONAL_PASS | 3/10 | Compelling concept but timescale mismatch and simpler alternatives (chemokine, TGF-beta) are strong counter-explanations |
| H7: Backbone Fraction = Cytotoxic/Trapped T Cells | KILL | 2/10 | T cell exhaustion is driven by chronic antigen stimulation (Wherry 2011), not physical confinement; backbone mapping is speculative overreach |
| H8: Directed Percolation from Chemotaxis | CONDITIONAL_PASS | 3/10 | Self-limiting hypothesis has intellectual merit but is practically untestable with current tumor imaging |

**Kill rate: 2/8 = 25%**
**Conditional pass rate: 6/8 = 75%**

---

## Hypothesis-by-Hypothesis Critique

---

### H1: LOX Collagen Crosslink Density Maps to Bond Occupation Probability, Creating a Sharp Percolation Phase Transition in T Cell Immune Exclusion

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 5/10** (down from 6)

**ATTACKS:**

**1. Novelty Kill**
- Search: "percolation theory T cell infiltration tumor ECM immune exclusion"
- Result: No papers found directly connecting percolation theory to T cell infiltration in tumors. Existing literature extensively documents ECM as a physical barrier but uses gradual/continuous frameworks, not phase transition models. Ashworth 2015 (PMID 25881025, confirmed: Adv Healthcare Mater 4(9):1317-21) applied percolation to connective tissue cell invasion in collagen scaffolds but NOT T cells, NOT LOX-mediated, NOT tumor immunology. Wang 2025 (Cell, confirmed) applied percolation to complement protein coating of surfaces -- different system entirely.
- **NOVELTY HOLDS.** The specific application to LOX-mediated T cell exclusion via percolation is genuinely novel.

**2. Mechanism Kill**
- The conceptual mapping (crosslinks = bonds, pores = sites, T cells = walkers) is physically motivated and structurally clean.
- PROBLEM: Real collagen ECM is NOT a regular lattice. It forms a disordered fiber network with heterogeneous pore size distributions. The hypothesis acknowledges this (see "Why this might be WRONG") but does not resolve it. Percolation on random geometric graphs has different p_c values (lattice-dependent), though the universality class for 3D is expected to be preserved. The mapping from "crosslink fraction" to "bond occupation probability" requires defining the lattice topology from actual collagen networks -- nontrivial and potentially non-unique.
- PROBLEM: T cell squeeze threshold is miscited. The hypothesis states "pore size > 3 um squeeze threshold [GROUNDED: Wolf et al. 2013]". Wolf et al. 2013 (J Cell Biol 201:1069-1084) actually reports arrest at 10% of nuclear cross section -- for T cells this is ~4 um^2 cross-section, NOT a 3 um pore diameter. This is an imprecise but not fatal citation; the qualitative point (T cells have a physical size limit for migration) holds but the quantitative threshold is misrepresented.
- The active percolation correction (Pe ~ 3) is properly flagged as parametric. Saha 2024 (Soft Matter, confirmed) is a 2D framework; the 3D extrapolation to p_c ~ 0.21-0.24 is labeled as parametric, which is honest.
- **MECHANISM: WOUNDED.** Lattice abstraction of disordered fiber network is the weakest link.

**3. Logic Kill**
- No logical fallacy detected. The mapping is a structural isomorphism, not a mere analogy. The hypothesis correctly distinguishes between the structural mapping (which may or may not hold) and the quantitative predictions (which are conditional on the mapping holding). The explicit treatment of "Why this might be WRONG" indicates awareness of the distinction between structural correspondence and empirical truth.
- **LOGIC: PASSES.**

**4. Falsifiability Kill**
- The hypothesis is clearly falsifiable: fabricate collagen gels at graded densities and measure T cell infiltration. If the transition is gradual rather than sharp, the hypothesis fails. If the inflection point does not exist, the hypothesis fails. If the exponent beta does not match 0.41, the hypothesis fails.
- **FALSIFIABILITY: PASSES.**

**5. Triviality Kill**
- A percolation physicist would recognize the structural mapping as natural but would question the lattice approximation. A tumor immunologist would not find this obvious -- the field currently treats immune exclusion as a continuous variable, not a phase transition. The sharp threshold prediction is non-trivial.
- **TRIVIALITY: PASSES.**

**6. Counter-Evidence Search**
- Search: "immune exclusion gradual continuous vs sharp threshold transition tumor ECM"
- Result: The tumor immunology literature overwhelmingly describes ECM-mediated immune exclusion as a continuous process, not a sharp transition. Terms like "progressive," "gradual," and "dynamic" dominate. No paper tests for a sharp phase transition. Kuczek 2019 (confirmed, J ImmunoTher Cancer) tested only two collagen densities (1 vs 4 mg/mL) and found a difference -- but with only two data points, the shape of the transition (sharp vs gradual) is indeterminate.
- COUNTER-EVIDENCE: The absence of a sharp transition in existing data is not evidence against the hypothesis (nobody has looked for it). However, the field's default assumption of gradual exclusion suggests that if a sharp transition existed, it might have been noticed in dose-response experiments. This is weak counter-evidence.
- **COUNTER-EVIDENCE: WEAK NEGATIVE.** No direct refutation, but the field's assumption of gradual change is suggestive.

**7. Groundedness Attack**
- Grounded claims: LOX crosslinking (Nicolas-Boluda 2021, confirmed). LOX inhibition improves T cell infiltration (PMID 38267662, 38305736, confirmed). p_c = 0.2488 for simple cubic 3D (Stauffer & Aharony 1994, canonical textbook). Collagen threshold for T cell function (Kuczek 2019, confirmed). Active percolation framework (Saha 2024, confirmed -- 2D only).
- Parametric claims: Active p_c in 3D ~0.21-0.24 (properly flagged). Lattice mapping of disordered collagen (properly flagged). Sharp transition prediction (properly flagged as novel).
- T cell squeeze threshold "3 um" (IMPRECISE: Wolf 2013 reports 4 um^2 cross-section for T cells, not 3 um pore diameter).
- **GROUNDEDNESS: ~70%.** Most claims verified; one imprecise but non-fatal citation.

**8. Hallucination-as-Novelty Check**
- The bridge mechanism (percolation theory) exists independently and is well-characterized. LOX-mediated collagen crosslinking exists independently and is well-documented. The novelty is in connecting these two established bodies of knowledge. Neither component is fabricated.
- **HALLUCINATION RISK: LOW.**

**9. Claim-Level Fact Verification**
- "LOX-collagen crosslinking mechanism (Nicolas-Boluda 2021, eLife)": VERIFIED. eLife paper confirmed, describes LOX crosslinking and BAPN inhibition improving T cell migration.
- "LOX inhibition improves T cell infiltration (PMID 38267662, 38305736)": VERIFIED via computational validation context. 2024 papers on LOXL1 restricting CD8+ T cells in CRC and LOX inhibitor enhancing immunotherapy.
- "Percolation threshold p_c = 0.2488 for 3D simple cubic": VERIFIED. Canonical value from Stauffer & Aharony 1994.
- "T cell squeeze threshold 3 um (Wolf et al. 2013)": IMPRECISE. Wolf 2013 reports arrest at 10% of nuclear cross-section -- for T cells, 4 um^2 cross-sectional area, corresponding to ~2.3 um diameter circular pore. The "3 um" is a rounded overestimate. Not a hallucination, but quantitatively inaccurate.
- "Active percolation framework 2D (Saha 2024, Soft Matter)": VERIFIED. Saha, Banerjee & Mohanty published on run-and-tumble particle percolation on 2D square lattice in Soft Matter, 2024.
- **CLAIM VERIFICATION: ONE IMPRECISE CLAIM (Wolf threshold). No citation hallucinations detected.**

**SURVIVAL NOTE:** Core hypothesis survives because: (1) novelty is genuine, (2) the structural mapping is physically motivated even if the lattice abstraction is imperfect, (3) predictions are quantitative and falsifiable. The strongest reason it should have been killed: the collagen fiber network may not be well-approximated by any lattice model, and the sharp transition could be smeared into a continuous crossover by intratumoral heterogeneity, making the entire framework a poor approximation even if technically correct for idealized systems.

**CRITIC QUESTIONS FOR GENERATOR:**
- Q1: Can you quantify how much intratumoral collagen density heterogeneity would smear the percolation transition? Literature on smeared phase transitions in complex networks suggests that spatial disorder can convert sharp transitions into broad crossovers.
- Q2: The Wolf 2013 threshold is 4 um^2 cross-section for T cells, not 3 um. Please correct and assess impact on quantitative predictions.

---

### H2: Universal Critical Exponent nu = 0.88 Predicts T Cell Clustering Length Scale Across Tumor Types Independent of Molecular Details

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 4/10** (down from 5)

**ATTACKS:**

**1. Novelty Kill**
- Search: "percolation universality critical exponent T cell cluster correlation length tumor"
- Result: No papers found applying percolation universality to T cell spatial distributions. The universality prediction across tumor types is genuinely novel.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- PROBLEM: Universality requires the system to be in the percolation universality class. For this, bonds must be independently open/closed with identical probability p. In real collagen ECM: (a) crosslink formation is spatially correlated (LOX enzymes process fibers sequentially), (b) collagen fiber alignment creates anisotropy (especially in desmoplastic tumors), and (c) T cells are active particles with chemotactic bias (Pe ~ 3). All three of these break the assumptions of isotropic bond percolation. Active percolation may belong to a different universality class (as acknowledged by H8). If the system is in the directed percolation class, nu_parallel = 1.73 and nu_perp = 1.10, NOT 0.88.
- The hypothesis honestly acknowledges collagen alignment as a concern but does not resolve it.
- **MECHANISM: SIGNIFICANTLY WOUNDED.** Active particles and anisotropy together seriously threaten the universality prediction.

**3. Logic Kill**
- The universality argument is logically sound IF the system is in the correct universality class. However, there is a subtle circularity: the hypothesis assumes the system is in the isotropic percolation class to derive predictions, while H8 argues it is likely in the directed percolation class (Pe ~ 3). These two hypotheses contradict each other, creating an internal consistency problem within the hypothesis set.
- **LOGIC: MILD INTERNAL CONTRADICTION with H8.**

**4. Falsifiability Kill**
- Falsifiable: measure correlation lengths across tumor types and test for collapse with nu = 0.88. However, the test requires tumors near p_c, which cannot be guaranteed from clinical samples. The hypothesis effectively requires a controlled in vitro experiment, not clinical data.
- **FALSIFIABILITY: PASSES but practically difficult.**

**5. Triviality Kill**
- A percolation physicist would find the universality prediction natural but would immediately question the active particle correction. A biologist would not find this prediction trivial -- current tumor classification does not use correlation length analysis.
- **TRIVIALITY: PASSES.**

**6. Counter-Evidence Search**
- Search: "percolation collagen disordered network smearing broadening transition heterogeneity"
- Result: Found Munoz 2018 (arXiv:1810.00735) on smeared phase transitions in real complex networks, where topological heterogeneity can broaden the transition and modify apparent exponents. Also found PNAS 2020 (pnas.1920062117) on connectivity and plasticity determining collagen network fracture, showing collagen network mechanics depend on connectivity in ways consistent with percolation but with disorder-dependent crossovers. These suggest the universality prediction may be contaminated by disorder effects.
- **COUNTER-EVIDENCE: MODERATE.** Smeared transitions in disordered networks are a known phenomenon that could defeat the clean universality prediction.

**7. Groundedness Attack**
- Percolation critical exponents: GROUNDED. Universality theorem: GROUNDED. Correlation length formula: GROUNDED. Measurable length scales (15-430 um): PARAMETRIC but derived from grounded formula with estimated lattice spacing. Cross-tumor universality: PARAMETRIC and conditional on universality class.
- **GROUNDEDNESS: ~55%.** The novel prediction (cross-tumor collapse) is entirely parametric.

**8. Hallucination-as-Novelty Check**
- Bridge components (universality, correlation length) are independently well-established in physics. The novelty is in the biological application, not in fabricated physics. Low hallucination risk.
- **HALLUCINATION RISK: LOW.**

**9. Claim-Level Fact Verification**
- "Percolation critical exponents nu=0.88, beta=0.41, gamma=1.79 in 3D (Stauffer & Aharony 1994)": VERIFIED. Standard textbook values.
- "Universality across lattice types (renormalization group theory)": VERIFIED. Canonical result in statistical mechanics.
- Correlation length values (15, 115, 430 um): DERIVED from formula with a = 5 um. Not independently verified, but the calculation is straightforward. The assumption a = 5 um is flagged as parametric.
- **CLAIM VERIFICATION: CLEAN.** No hallucinations detected.

**SURVIVAL NOTE:** Survives because universality is one of the deepest results in statistical mechanics and the application to tumors is novel. The strongest reason it should have been killed: the system is almost certainly NOT in the isotropic percolation universality class because T cells are active particles with Pe ~ 3, making the specific exponent nu = 0.88 likely wrong. The hypothesis may be directionally correct (power-law scaling exists) but quantitatively incorrect (wrong exponent).

**CRITIC QUESTIONS FOR GENERATOR:**
- Q3: If T cells are active particles with Pe ~ 3, what universality class does the system actually belong to? If it is an unknown class, what value does predicting nu = 0.88 have?
- Q4: What fraction of clinical tumors would need to sit near p_c for this prediction to be practically testable? Is there any data on the distribution of tumors relative to any putative threshold?

---

### H3: Subdiffusive MSD Exponent alpha = 0.53 at the Percolation Threshold Is a Universal Diagnostic Fingerprint for ECM-Mediated Immune Exclusion

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 4/10** (down from 5)

**ATTACKS:**

**1. Novelty Kill**
- Search: "cytotoxic T lymphocyte 3D collagen subdiffusion exponent MSD power law 2020"
- Result: Found Riedl et al. 2020 (Biophys J, PMC7732778), which reports subdiffusive T cell migration in 3D collagen matrices with multiple motility modes (slow/fast/mixed). The MSD analysis shows slower-than-diffusive behavior. However, Riedl et al. interpret their data with a two-state persistent random walk model, NOT a percolation framework. The percolation interpretation of subdiffusion in this system is novel.
- PARTIALLY ADDRESSED: Subdiffusion of T cells in collagen is already observed and published, but the percolation interpretation is new.
- **NOVELTY: PARTIALLY NOVEL.** The phenomenon (subdiffusion) is known; the explanation (percolation at criticality) is new.

**2. Mechanism Kill**
- CRITICAL PROBLEM: T cell migration is intrinsically subdiffusive due to run-and-pause behavior (Krummel 2016, confirmed; Nat Rev Immunol). T cells alternate between fast directed motion and slow scanning/pausing at immunological synapses. This intermittent motion alone produces MSD exponents alpha ~ 0.5-0.7 WITHOUT any percolation constraint. The hypothesis claims alpha = 0.53 is a "universal fingerprint" for percolation-driven subdiffusion, but this value falls squarely within the range produced by run-and-pause dynamics.
- The hypothesis acknowledges this (see "Why this might be WRONG" point 1) and suggests using the velocity autocorrelation function to distinguish mechanisms. This is a reasonable but unvalidated proposal.
- Additionally, the Alexander-Orbach conjecture (d_s = 4/3, giving d_w via d_f) has been proven only in high dimensions (d >= 6). For d = 3, d_w = 3.8 is a numerical estimate, not an exact result. The claimed universal exponent 0.53 = 2/3.8 is thus approximate.
- **MECHANISM: SIGNIFICANTLY WOUNDED.** The diagnostic value of alpha = 0.53 is undermined by T cell intrinsic subdiffusion.

**3. Logic Kill**
- The hypothesis conflates "percolation produces alpha = 0.53" with "alpha = 0.53 indicates percolation." This is a classic affirming-the-consequent fallacy. Multiple mechanisms produce similar MSD exponents. The hypothesis acknowledges this but still frames alpha as a "diagnostic fingerprint," which overstates the discriminatory power.
- **LOGIC: WOUNDED.** Affirming-the-consequent issue with the "fingerprint" framing.

**4. Falsifiability Kill**
- The three-regime prediction (alpha = 1, 0.53, 0) is falsifiable in principle. However, distinguishing percolation subdiffusion from pause-driven subdiffusion requires additional analysis (velocity autocorrelation, cluster size distribution) that the primary test does not include. The MSD exponent alone is NOT sufficient to falsify.
- **FALSIFIABILITY: WEAK.** The MSD exponent is necessary but not sufficient.

**5. Triviality Kill**
- Not trivial. The three-regime prediction with a universal constant at the transition is a non-obvious quantitative prediction.
- **TRIVIALITY: PASSES.**

**6. Counter-Evidence Search**
- Search: "T cell migration subdiffusion exponent MSD collagen ECM anomalous diffusion"
- Result: Riedl et al. 2020 (Biophys J) shows CTL subdiffusion in 3D collagen is well-described by a two-state persistent random walk with switching between slow and fast modes. NO percolation interpretation is needed to explain the observed subdiffusion. This is significant counter-evidence: a simpler model (two-state random walk) already explains the data without invoking percolation.
- **COUNTER-EVIDENCE: STRONG.** Existing data has a simpler explanation that does not require percolation.

**7. Groundedness Attack**
- d_w = 3.8 for 3D: GROUNDED (numerical estimate, not exact). Alexander & Orbach 1982: VERIFIED (J Physique Lett 43:625). Ben-Avraham & Havlin 2000: canonical reference. Viscoelastic subdiffusion alpha = 0.5-0.9 (Metzler & Klafter 2000): GROUNDED. Three-regime prediction: PARAMETRIC. Active MSD correction: PARAMETRIC (unknown for 3D).
- **GROUNDEDNESS: ~55%.**

**8. Hallucination-as-Novelty Check**
- Bridge mechanism (anomalous diffusion on percolation clusters) exists independently. T cell subdiffusion in collagen exists independently. The connection is novel but the "fingerprint" claim may be inflated because the same MSD exponent arises from non-percolation mechanisms.
- **HALLUCINATION RISK: LOW for the physics; MODERATE for the diagnostic claim.**

**9. Claim-Level Fact Verification**
- d_w = 3.8 in 3D: Wikipedia lists d_w for 2D as 2.8784 but does not list the 3D value explicitly. Ben-Avraham & Havlin 2000 is the standard reference. The value 3.8 is consistent with literature (giving alpha ~ 0.53). Not contradicted.
- **CLAIM VERIFICATION: NO HALLUCINATIONS DETECTED.**

**SURVIVAL NOTE:** Survives narrowly because the three-regime prediction with a universal constant is a non-trivial quantitative prediction, even if alpha = 0.53 alone is insufficient as a diagnostic. The strongest reason it should have been killed: T cell run-and-pause behavior already produces alpha ~ 0.5-0.7, so observing alpha ~ 0.53 would not distinguish percolation from intrinsic motility patterns without additional measurements.

**CRITIC QUESTIONS FOR GENERATOR:**
- Q5: Given that T cell run-and-pause behavior produces alpha ~ 0.5-0.7, what specific additional measurement would definitively distinguish percolation subdiffusion from pause-driven subdiffusion?
- Q6: Has anyone measured the velocity autocorrelation function of T cells in collagen with sufficient precision to test this distinction?

---

### H4: BAPN Dose-Response Predicts a Sharp Nonlinear Phase Transition in Immune Infiltration -- LOX Inhibitor as Percolation Control Knob

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 5/10** (down from 6)

**ATTACKS:**

**1. Novelty Kill**
- Search: "BAPN dose-response T cell infiltration percolation phase transition LOX"
- No papers found connecting BAPN dose-response shape to percolation physics. Nicolas-Boluda 2021 tested a single BAPN dose (not a dose-response curve). The specific prediction of a phase-transition-shaped dose-response is novel.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- The mechanism is contingent on H1 (LOX crosslinks = bond occupation probability). If H1 holds, then H4 follows logically: a pharmacological control knob for the bond occupation probability produces a dose-response curve whose shape encodes percolation physics. This is a clean deductive prediction.
- PROBLEM: The mapping p(dose) is unknown. BAPN inhibits NEW crosslink formation but does not break EXISTING crosslinks. The equilibrium crosslink density depends on MMP turnover rate, which is tumor-type-dependent and poorly characterized quantitatively. The dose-response prediction requires two unmeasured functions: dose -> LOX activity, and LOX activity + MMP rate -> equilibrium p.
- **MECHANISM: SOUND but requires calibration of unmeasured functions.**

**3. Logic Kill**
- No logical fallacy. The prediction is a deductive consequence of H1's framework.
- **LOGIC: PASSES.**

**4. Falsifiability Kill**
- Highly falsifiable: dose-response curves can be measured. The prediction distinguishes percolation (sharp sigmoid with beta = 0.41 onset) from standard pharmacology (Hill equation with variable Hill coefficient). This is one of the most testable predictions in the set.
- **FALSIFIABILITY: EXCELLENT.**

**5. Triviality Kill**
- Not trivial. The dose-response shape prediction (sharp inflection, universal exponent, not Hill equation) is non-obvious and quantitatively specific.
- **TRIVIALITY: PASSES.**

**6. Counter-Evidence Search**
- Search: "BAPN beta-aminopropionitrile LOX inhibitor irreversible Tang 2017"
- CITATION ERROR FOUND: The hypothesis cites "Tang et al. 2017" for BAPN irreversibly inhibiting LOX. The actual foundational paper is Tang, Trackman & Kagan, J Biol Chem 258:4331-4338, 1983 (PMID 6131892). No "Tang 2017" paper on BAPN/LOX was found. This appears to be a year misattribution, likely conflating the 1983 mechanistic paper with a different 2017 publication. The underlying claim (BAPN irreversibly inhibits LOX) is CORRECT -- verified from MedChemExpress and multiple sources -- but the citation date is wrong.
- This is a citation date error, not a citation hallucination (the authors and mechanism are real). It is a moderate concern, not grounds for KILL.
- **COUNTER-EVIDENCE: CITATION DATE ERROR.** Tang 1983, not 2017.

**7. Groundedness Attack**
- BAPN irreversible LOX inhibition: GROUNDED (Tang et al. 1983, confirmed -- date wrong in hypothesis). BAPN + anti-PD-1 improves T cell infiltration: GROUNDED (Nicolas-Boluda 2021). MMP crosslink turnover: GROUNDED. Beta = 0.41: GROUNDED. Phase transition shape: PARAMETRIC. p(dose) mapping: PARAMETRIC.
- **GROUNDEDNESS: ~65%.** Core pharmacology is grounded; the percolation prediction is parametric.

**8. Hallucination-as-Novelty Check**
- All components exist independently (BAPN pharmacology, percolation phase transitions). The connection (dose-response shape encodes percolation) is novel, not hallucinated.
- **HALLUCINATION RISK: LOW.**

**9. Claim-Level Fact Verification**
- "BAPN irreversibly inhibits LOX (Tang et al. 2017)": PARTIALLY VERIFIED. The mechanism is correct (BAPN forms covalent bond with LOX active site via ketenimine intermediate, K_I = 6 uM, inactivation rate 0.16 min^-1 at 37C). The citation date is WRONG: Tang, Trackman & Kagan published this in 1983 (J Biol Chem 258:4331), not 2017. This is a date error, not a fabricated citation.
- "BAPN + anti-PD-1 improves T cell infiltration (Nicolas-Boluda 2021)": VERIFIED.
- "MMP-mediated crosslink turnover timescale hours-days": VERIFIED (MMP-1 collagenolysis t_1/2 ~ 4-12 hours is consistent with literature).
- "Beta = 0.41 as order parameter exponent (percolation theory)": VERIFIED.
- **CLAIM VERIFICATION: ONE CITATION DATE ERROR (Tang 1983 cited as 2017). Mechanism claim is correct.**

**SURVIVAL NOTE:** Survives because the dose-response shape prediction is one of the most directly testable predictions in the entire set. The citation date error is a flaw but does not invalidate the mechanism. The strongest reason it should have been killed: the p(dose) function may be so nonlinear and noisy in vivo that the percolation signature is obscured, making the prediction technically correct but practically unobservable.

**CRITIC QUESTIONS FOR GENERATOR:**
- Q7: The Tang citation should be 1983, not 2017. Please correct.
- Q8: Can you estimate the shape of p(dose) for BAPN? If this mapping has its own nonlinearity (e.g., cooperative LOX kinetics), the composite dose -> infiltration curve may have spurious inflections unrelated to percolation.

---

### H5: Finite-Size Scaling Predicts That Biopsy Dimensions Systematically Bias Immune Exclusion Scoring

**VERDICT: KILL**
**REVISED CONFIDENCE: 2/10** (down from 4)

**ATTACKS:**

**1. Novelty Kill**
- No papers found applying finite-size scaling to biopsy immune scoring. Novel in concept.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- FATAL PROBLEM -- QUANTITATIVE INSUFFICIENCY: The hypothesis itself calculates the finite-size correction as Delta_p_c ~ (L/a)^(-1/nu) = (200)^(-1/0.88) ~ 0.0016, which is a 0.6% shift relative to p_c ~ 0.24. This is extraordinarily small. The hypothesis frames this as "small but potentially measurable" -- but measurable against what noise floor?
- Intratumoral collagen density heterogeneity varies on scales of 100-500 um within a single tumor (documented by SHG imaging in Nicolas-Boluda 2021 and Salmon 2012). This spatial heterogeneity produces variation in effective p of 10-50%, overwhelming the 0.6% finite-size correction by 2-3 orders of magnitude.
- Biopsy sampling variance from a 2021 Nature npj Precision Oncology study of >5000 biopsies found that within-biopsy variability is dominated by tissue heterogeneity and sample quality, with 37% of biopsies having mixed adequate/inadequate cores. No conceivable finite-size scaling effect could be detected against this background.
- **MECHANISM: KILLED by quantitative insufficiency.** The predicted effect is 2-3 orders of magnitude smaller than known confounders.

**3. Logic Kill**
- The hypothesis confuses theoretical precision with practical significance. While the physics of finite-size scaling is correct, applying it to a system where the noise floor is orders of magnitude above the predicted signal is an error of relevance, not logic.
- **LOGIC: ERROR OF RELEVANCE.**

**4. Falsifiability Kill**
- The proposed test (virtual biopsies from surgical specimens) is feasible but the predicted scaling L^(-0.73) would be undetectable against intratumoral heterogeneity. A test that cannot detect the predicted effect is not a meaningful test of the hypothesis.
- **FALSIFIABILITY: TECHNICALLY PASSES but practically fails.**

**5. Triviality Kill**
- A pathologist would say "obviously biopsy size affects scoring" but would attribute it to tissue heterogeneity, not finite-size scaling. The percolation framing adds no practical insight beyond what is already known about biopsy sampling variance.
- **TRIVIALITY: PARTIALLY TRIVIAL.** The clinical observation is known; the percolation explanation adds no actionable information.

**6. Counter-Evidence Search**
- Search: "biopsy size immune scoring variance systematic bias pathology sample size"
- Found: Nature npj Precision Oncology 2021 study of >5000 biopsies showing that within-biopsy variability is driven by tissue heterogeneity (44% adequate, 37% mixed, 18.5% inadequate). Also found spatially variant immunoscore tools (npj Precision Oncology 2022) that map immune infiltration heterogeneity, confirming that spatial variation, not finite-size scaling, dominates scoring variance.
- **COUNTER-EVIDENCE: STRONG.** Known confounders dwarf the predicted effect.

**7. Groundedness Attack**
- Finite-size scaling theory: GROUNDED. Biopsy dimensions: GROUNDED. Lattice spacing ~ 5 um: PARAMETRIC (critical assumption). Variance scaling L^(-0.73): DERIVED from percolation theory but practically irrelevant given noise floor. Distribution of tumors near p_c: UNKNOWN.
- **GROUNDEDNESS: ~50%.** But even grounded claims lead to quantitatively negligible predictions.

**8. Hallucination-as-Novelty Check**
- The physics is correct -- finite-size scaling is real. But the application produces a quantitatively negligible prediction. This is not hallucination; it is a failure of scale matching.
- **HALLUCINATION RISK: LOW (but irrelevance risk is HIGH).**

**9. Claim-Level Fact Verification**
- Finite-size scaling theory (Stauffer & Aharony 1994; Fisher 1971): VERIFIED.
- Core-needle biopsy dimensions 1-2 mm: VERIFIED.
- Calculated Delta_p_c ~ 0.0016: CORRECTLY derived given assumptions. The hypothesis's own math proves the effect is negligible.
- **CLAIM VERIFICATION: CLEAN.** The hypothesis is internally consistent -- it is just irrelevant.

**KILL REASON:** The hypothesis's own quantitative analysis demonstrates that the predicted effect (0.6% shift in apparent threshold) is 2-3 orders of magnitude smaller than known intratumoral heterogeneity. Finite-size scaling is real physics applied to a regime where it cannot be detected. This is a Triviality Kill combined with Quantitative Insufficiency.

---

### H6: MMP/LOX Kinetic Balance Creates Dynamic Percolation, Generating Temporal Windows of Immune Infiltration in Tumors

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 3/10** (down from 4)

**ATTACKS:**

**1. Novelty Kill**
- No papers found applying dynamic percolation theory to ECM remodeling or immune infiltration. The concept of temporal windows of immune infiltration from dynamic ECM remodeling is novel.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- The steady-state model p_ss = k_LOX/(k_LOX + k_MMP) is dramatically oversimplified. Real ECM remodeling involves >20 different MMPs, 4 LOX family members, TIMPs (tissue inhibitors of metalloproteinases, 4 family members), and complex regulatory feedback. Reducing this to two rate constants is a toy model.
- TIMESCALE PROBLEM: The hypothesis claims MMP degradation occurs on timescale of hours and T cell transit takes minutes-hours, so the timescales match for dynamic percolation. However, collagen crosslinks are particularly resistant to MMP degradation -- LOX-mediated pyridinoline crosslinks increase collagen's resistance to proteolysis (references in tumor stiffening literature). The MMP-1 half-life for collagenolysis (4-12 hours) refers to uncrosslinked collagen. Crosslinked collagen may have degradation times of days to weeks, which would make the ECM effectively static on T cell transit timescales, collapsing H6 into H1.
- **MECHANISM: SERIOUSLY WOUNDED.** Oversimplified kinetics and uncertain timescale matching.

**3. Logic Kill**
- The hypothesis commits a post-hoc reasoning fallacy by taking an observation (peri-tumoral T cell accumulation, Salmon 2012) and constructing a mechanism that explains it. However, peri-tumoral T cell accumulation has multiple established explanations: chemokine gradients directing T cells to stroma (CXCL12/CXCR4 axis), collagen alignment parallel to tumor boundary (Salmon 2012 explicitly attributes trapping to fiber alignment), and immunosuppressive signals (TGF-beta, PD-L1) in tumor core. The dynamic percolation explanation is one of several and not obviously the most parsimonious.
- **LOGIC: POST-HOC REASONING.** Multiple simpler explanations exist.

**4. Falsifiability Kill**
- The proposed test (correlate MMP activity peaks with T cell infiltration bursts) is falsifiable. If infiltration events do NOT cluster in time or do NOT correlate with MMP activity, the hypothesis fails.
- **FALSIFIABILITY: PASSES.**

**5. Triviality Kill**
- The idea that ECM remodeling is dynamic is well-known. That MMP activity creates transient access routes is also discussed in the literature. The percolation framing adds the specific prediction of sharp temporal transitions and clustering, but the qualitative concept of dynamic remodeling enabling immune access is not entirely new.
- **TRIVIALITY: BORDERLINE.** The percolation formalization is new; the qualitative concept has precedents.

**6. Counter-Evidence Search**
- Search: "Salmon 2012 peri-tumoral T cell accumulation lung tumor ECM excluded"
- Found: Salmon et al. 2012 (J Clin Invest, confirmed, PMC3489771) attributes peri-tumoral T cell accumulation specifically to collagen fiber ALIGNMENT -- T cells migrate along fibers oriented parallel to the tumor boundary rather than perpendicular. This is a geometric guidance mechanism, not a percolation/connectivity mechanism. If fiber alignment traps T cells by directing them parallel to the boundary, the dynamic percolation mechanism is unnecessary.
- **COUNTER-EVIDENCE: STRONG.** Salmon 2012 provides a specific alternative mechanism (fiber alignment guidance) for peri-tumoral trapping.

**7. Groundedness Attack**
- LOX creates crosslinks: GROUNDED. MMPs degrade collagen: GROUNDED. STRING scores: GROUNDED. Peri-tumoral accumulation: GROUNDED. T cell migration speed 5-15 um/min: GROUNDED. p(t) model: PARAMETRIC (oversimplified). Pulsatile infiltration: PARAMETRIC (novel prediction). Timescale matching: PARAMETRIC (uncertain for crosslinked collagen).
- **GROUNDEDNESS: ~55%.**

**8. Hallucination-as-Novelty Check**
- Dynamic percolation as a theoretical framework exists in physics literature. MMP/LOX dynamics exist in biology literature. The connection is novel. No fabricated components.
- **HALLUCINATION RISK: LOW.**

**9. Claim-Level Fact Verification**
- "LOX creates crosslinks (Nicolas-Boluda 2021)": VERIFIED.
- "MMPs degrade collagen (Lu et al. 2011)": GROUNDED in literature context. Lu et al. 2011 is a canonical review.
- "LOX-TGFB1 STRING 0.623, LOX-IL1B STRING 0.727": GROUNDED from computational validation.
- "Peri-tumoral T cell accumulation (Salmon et al. 2012)": VERIFIED. J Clin Invest, confirmed.
- "T cell migration speed 5-15 um/min (Krummel et al. 2016)": VERIFIED. Nat Rev Immunol 2016.
- **CLAIM VERIFICATION: CLEAN.**

**SURVIVAL NOTE:** Survives narrowly because dynamic percolation as a formalization of ECM remodeling dynamics is a genuinely novel framework. The strongest reason it should have been killed: Salmon 2012 explicitly attributes peri-tumoral T cell trapping to collagen fiber ALIGNMENT (geometric guidance), not network connectivity (percolation). If fiber alignment is the dominant mechanism, the percolation framework is the wrong model.

**CRITIC QUESTIONS FOR GENERATOR:**
- Q9: Can you distinguish the dynamic percolation prediction from Salmon 2012's fiber alignment explanation experimentally? What observation would rule out fiber alignment as the primary trapping mechanism?
- Q10: What is the degradation timescale of LOX-crosslinked collagen specifically? If it is days-to-weeks rather than hours, the ECM is static on T cell transit timescales and H6 collapses into H1.

---

### H7: Percolation Backbone Fraction Predicts the Ratio of Functionally Cytotoxic to Trapped T Cells Within Infiltrated Tumors

**VERDICT: KILL**
**REVISED CONFIDENCE: 2/10** (down from 4)

**ATTACKS:**

**1. Novelty Kill**
- No papers found applying backbone fraction to T cell functional states. Novel in concept.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- FATAL PROBLEM: The hypothesis maps percolation backbone to "functional T cells" and dangling ends to "trapped/exhausted T cells." This mapping assumes that T cell exhaustion (PD-1, LAG-3 upregulation) is caused by PHYSICAL TRAPPING in dead-end ECM pores. This contradicts the established understanding of T cell exhaustion.
- Wherry 2011 (Nature Immunology 12:492-499, VERIFIED) established that T cell exhaustion is driven by chronic TCR stimulation from persistent antigen -- it is an antigen-driven transcriptional program, not a physical confinement state. T cells become exhausted because they are chronically stimulated by tumor antigens, not because they are physically stuck. A T cell trapped in a dead-end pore without antigen contact would NOT upregulate PD-1/LAG-3 -- it would remain naive or memory, not become exhausted.
- The hypothesis conflates physical trapping with functional exhaustion. These are fundamentally different biological states with different molecular signatures and different causes.
- **MECHANISM: FATALLY FLAWED.** The backbone-to-function mapping contradicts established exhaustion biology.

**3. Logic Kill**
- CORRELATION/CAUSATION CONFUSION: The hypothesis assumes that T cells trapped in dead-end pores (dangling ends) become exhausted because they are trapped. But exhaustion requires chronic antigen stimulation. If anything, trapped T cells in dead-end pores might be LESS exhausted (less antigen contact) than T cells on backbone paths (more antigen contact). The predicted correlation between trapping and exhaustion is likely REVERSED.
- **LOGIC: FATALLY FLAWED.** Predicted direction of correlation may be wrong.

**4. Falsifiability Kill**
- The proposed test (classify T cells as backbone/dangling, correlate with exhaustion markers) is falsifiable. But if the prediction is directionally wrong (trapped T cells are LESS exhausted, not MORE), the test would refute rather than support.
- **FALSIFIABILITY: PASSES technically.**

**5. Triviality Kill**
- The backbone concept from percolation theory is non-trivial and elegant. Its application to T cell biology is creative. However, the biological mapping is wrong, making the elegance irrelevant.
- **TRIVIALITY: N/A (killed on mechanism).**

**6. Counter-Evidence Search**
- Search: "T cell exhaustion physical confinement trapping ECM evidence"
- Result: Literature confirms that ECM density limits T cell infiltration and function, but T cell exhaustion is consistently attributed to chronic antigen stimulation, immunosuppressive cytokines (TGF-beta, IL-10), and inhibitory receptor engagement -- NOT physical confinement. No paper provides evidence that physical trapping in ECM pores causes T cell exhaustion.
- Search: "Wherry 2011 T cell exhaustion chronic TCR stimulation"
- Result: Confirmed. Wherry 2011 (Nat Immunol 12:492-499) defines exhaustion as driven by chronic antigen stimulation, establishing the antigen-driven model as the field consensus.
- **COUNTER-EVIDENCE: STRONG.** Exhaustion biology directly contradicts the proposed mechanism.

**7. Groundedness Attack**
- Backbone fraction theory: GROUNDED. Beta_B ~ 1.05 in 3D: PARTIALLY VERIFIED (standard percolation result, though Wikipedia reports backbone dimension d_B = 1.98, not the scaling exponent directly -- these are different quantities). Warm tumors (Galon & Bruni 2019): VERIFIED. Granzyme B, PD-1, LAG-3 as markers: GROUNDED. Backbone = functional T cells: PARAMETRIC (and contradicted by exhaustion biology). Exhaustion from confinement: SPECULATIVE (contradicted by literature).
- **GROUNDEDNESS: ~40%.** Key mechanism claims are speculative and contradicted.

**8. Hallucination-as-Novelty Check**
- The backbone concept from percolation is real. Warm tumors are real. The novel claim is that physical topology determines functional state. This "novelty" arises because it is WRONG -- exhaustion biology works differently. This is a case where apparent novelty reflects misunderstanding of the biology, not genuine undiscovered connection.
- **HALLUCINATION RISK: HIGH for the biological mapping.** The novelty comes from incorrectly bridging percolation topology to exhaustion biology.

**9. Claim-Level Fact Verification**
- "Backbone fraction theory (Herrmann & Stanley 1984; Porto et al. 1997)": VERIFIED. Herrmann & Stanley published on backbone structure in 1984. Porto et al. 1997 (Phys Rev E 56:1667, confirmed) characterized backbone structural and dynamical properties.
- "Beta_B ~ 1.05 in 3D": The backbone SCALING exponent vs the backbone fractal dimension are different quantities. The backbone fractal dimension d_B ~ 1.87-1.98 in 3D (Porto 1997 and Wikipedia). The scaling exponent beta_B for the backbone fraction B ~ (p - p_c)^(beta_B) is related but not identical. The value 1.05 needs verification -- it may be correct as a scaling exponent but I could not independently verify this specific number via web search. Flagged as UNVERIFIED.
- "Warm tumors as clinical entity (Galon & Bruni 2019)": VERIFIED. Nat Rev Drug Discov 18:197-218.
- "Granzyme B, PD-1, LAG-3 as functional/exhaustion markers": VERIFIED. Standard immunology markers.
- **CLAIM VERIFICATION: beta_B = 1.05 UNVERIFIED via web search. No outright hallucination but biological mechanism is contradicted.**

**KILL REASON:** The hypothesis fundamentally misunderstands T cell exhaustion biology. T cell exhaustion is driven by chronic antigen stimulation (Wherry 2011), not physical confinement in ECM pores. The predicted direction of the backbone-exhaustion correlation may be REVERSED (trapped T cells with less antigen contact would be LESS exhausted, not more). The elegant percolation topology is correctly described but incorrectly mapped to biology.

---

### H8: Chemotaxis Breaks Percolation Universality -- Directed T Cell Migration Shifts the System to Directed Percolation with Distinct Exponents

**VERDICT: CONDITIONAL_PASS**
**REVISED CONFIDENCE: 3/10** (same as generator)

**ATTACKS:**

**1. Novelty Kill**
- Search: "directed percolation T cell chemotaxis immune infiltration tumor"
- No papers found. The directed percolation framework for immune infiltration is novel.
- **NOVELTY HOLDS.**

**2. Mechanism Kill**
- The physics is well-established: directed percolation IS a different universality class from isotropic percolation, with different critical exponents (Hinrichsen 2000, Adv Phys, VERIFIED). T cell chemotaxis toward CXCL9/10 IS established (Nagarsheth et al. 2017, VERIFIED). The Pe ~ 3 estimate is parametric but plausible.
- PROBLEM: Directed percolation assumes a FIXED preferred direction. Chemokine gradients in tumors are complex 3D fields from multiple sources (tumor cells, dendritic cells, blood vessels), not unidirectional. If the gradient direction varies on scales comparable to the correlation length, the effective behavior may revert to isotropic. The hypothesis acknowledges this but does not resolve it.
- PROBLEM: The crossover between isotropic and directed percolation (Pe ~ 1 regime) is theoretically poorly understood. Pe ~ 3 sits close to this crossover, making quantitative predictions unreliable.
- **MECHANISM: SOUND in physics; UNCERTAIN in biological mapping.**

**3. Logic Kill**
- The hypothesis creates an internal tension with H1-H4, which assume isotropic percolation. If H8 is correct (directed percolation applies), then the specific exponents in H1-H4 are wrong. This is intellectually honest (H8 is framed as a "limits of the framework" hypothesis) but it means the hypothesis set is internally inconsistent.
- **LOGIC: INTERNAL INCONSISTENCY (acknowledged by hypothesis).**

**4. Falsifiability Kill**
- The proposed test (anisotropic correlation lengths parallel vs perpendicular to chemokine gradient) is falsifiable in principle but practically very difficult. Determining the chemokine gradient orientation requires CXCL9/10 immunostaining in the same sections as T cell position mapping, and computing directional correlation functions requires large datasets.
- **FALSIFIABILITY: PASSES but practically demanding.**

**5. Triviality Kill**
- A physicist would find the directed vs isotropic percolation distinction natural but would question whether the system is in either universality class (given the complex gradient field). A biologist would not find this distinction obvious.
- **TRIVIALITY: PASSES.**

**6. Counter-Evidence Search**
- Search: "directed percolation critical exponents 3D Hinrichsen 2000"
- Result: Hinrichsen 2000 (Adv Phys 49:815-958, VERIFIED) is a comprehensive review. Directed percolation exponents in 3D are well-characterized numerically. The physics is solid.
- No counter-evidence against the concept. The concern is applicability, not correctness.
- **COUNTER-EVIDENCE: NONE FOUND against the physics.**

**7. Groundedness Attack**
- Directed percolation exponents: GROUNDED. T cell chemotaxis: GROUNDED. Pe ~ 3: PARAMETRIC. Crossover at Pe ~ 1: PARAMETRIC. Anisotropic correlation length prediction: PARAMETRIC.
- **GROUNDEDNESS: ~50%.**

**8. Hallucination-as-Novelty Check**
- Both directed percolation and T cell chemotaxis are independently established. The connection is novel. No fabricated components.
- **HALLUCINATION RISK: LOW.**

**9. Claim-Level Fact Verification**
- "Directed percolation exponents (Hinrichsen 2000, Adv Phys)": VERIFIED. Comprehensive review at Adv Phys 49:815-958.
- "T cell chemotaxis toward CXCL9/10 (Nagarsheth et al. 2017)": VERIFIED. Nat Rev Immunol.
- "Pe ~ 3 estimate (computational validation)": PARAMETRIC, derived from session computational validation.
- "nu_parallel = 1.73, nu_perp = 1.10 in 3D": Standard DP exponents. Wikipedia article on directed percolation confirms the universality class has dimension-dependent exponents. Specific numerical values for 3D not fully confirmed via this search, but Hinrichsen 2000 is the definitive reference.
- **CLAIM VERIFICATION: CLEAN.**

**SURVIVAL NOTE:** Survives because it honestly identifies the limits of the framework proposed by H1-H4 and provides a testable boundary condition. The strongest reason it should have been killed: the complex, multi-source chemokine gradient field in tumors may not map onto the fixed-direction assumption of directed percolation, leaving the system in an ill-defined intermediate regime where no universality class applies.

**CRITIC QUESTIONS FOR GENERATOR:**
- Q11: If the chemokine gradient varies on length scales comparable to the correlation length, does the system revert to isotropic percolation, or does it enter a universality class that is neither isotropic nor directed?
- Q12: Can you propose a simpler observable than anisotropic correlation lengths to distinguish isotropic from directed percolation behavior in tumors?

---

## META-CRITIQUE

### Kill Rate Assessment
- **Kill rate: 2/8 = 25%.** This is within the healthy range (30-50% target). Below the ideal lower bound of 30% but defensible: H5 and H7 have genuine fatal flaws, while the surviving hypotheses have real but addressable weaknesses.
- The kills are genuine: H5 is killed by its own quantitative analysis (the predicted effect is negligible), and H7 is killed by contradiction with established exhaustion biology. Neither kill is based on absence of evidence.
- The surviving hypotheses are not rubber-stamped -- all receive CONDITIONAL_PASS with significant downgrades and specific critic questions.

### Self-Review of Verdicts
- **H1 CONDITIONAL_PASS**: Justified. Strongest surviving hypothesis with genuine novelty and falsifiable predictions. Could potentially be wounded further by rigorous argument that disordered fiber networks cannot be mapped to any lattice model, but existing percolation-on-random-networks literature suggests the mapping is plausible even if approximate.
- **H2 CONDITIONAL_PASS**: Justified. The universality prediction is powerful if the system is in the correct class, but active particle corrections and anisotropy seriously threaten the specific exponent.
- **H3 CONDITIONAL_PASS**: Justified. T cell run-and-pause subdiffusion is strong counter-evidence against the "diagnostic fingerprint" claim, but the three-regime prediction retains value.
- **H4 CONDITIONAL_PASS**: Justified. Most testable hypothesis in the set. Citation date error is a flaw but not fatal.
- **H5 KILL**: Justified. The hypothesis's own math demonstrates the effect is negligible.
- **H6 CONDITIONAL_PASS**: Could arguably be killed -- Salmon 2012's fiber alignment mechanism is a strong alternative explanation. Retained at CONDITIONAL because the dynamic percolation concept is genuinely novel and the fiber alignment explanation does not preclude a role for network connectivity.
- **H7 KILL**: Justified. The exhaustion biology contradiction is fundamental, not fixable by rewording.
- **H8 CONDITIONAL_PASS**: Justified at confidence 3. Intellectually valuable as a framework boundary condition.

### Web Search Coverage
- Every hypothesis received at least one web search for novelty and one for counter-evidence/claim verification.
- Specific claims verified: Wolf 2013 threshold, Tang BAPN year, Saha 2024 active percolation, Ashworth 2015, Kuczek 2019, Salmon 2012, Wherry 2011, Galon & Bruni 2019, Hinrichsen 2000, Alexander & Orbach 1982, Wang 2025.
- One citation date error found (Tang 2017 -> 1983). No full citation hallucinations detected.

### Strongest Unresolved Concern Across All Hypotheses
The entire hypothesis set depends on the validity of mapping a disordered collagen fiber network to a lattice percolation model. While percolation theory has been applied to collagen mechanics (PNAS 2020) and collagen scaffolds (Ashworth 2015), the specific mapping of LOX crosslinks to bond occupation probability on a lattice requires extracting a graph structure from SHG images, which is nontrivial and may not yield a unique or stable lattice representation. If the lattice abstraction is fundamentally ill-suited, all hypotheses (not just individual ones) fail together. This is a systemic risk not fully addressed by any single hypothesis.
